HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form

Retrovirology

Volumn 7, Issue , 2010, Pages

  de Silva, Thushan I ^a,b   Turner, Roxanne ^a   Hué, Stéphane ^b   Trikha, Roochi ^a   van Tienen, Carla ^a   Onyango, Clayton ^a   Jaye, Assan ^a   Foley, Brian ^d   Whittle, Hilton ^a   Rowland Jones, Sarah L ^c   Cotten, Matthew ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CIRCULATING RECOMBINANT FACTOR 49; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CENTRAL AFRICA; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; FEMALE; GAMBIA; GENE CLUSTER; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS ENVELOPE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING; ADOLESCENT; CLASSIFICATION; GENETIC RECOMBINATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; PHYLOGENY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; FEMALE; GAMBIA; GENOME, VIRAL; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS;

EID: 77957597709     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-82     Document Type: Article

References (45)

1. Schim van der Loeff MF, Sarge-Njie R, Ceesay S, Awasana AA, Jaye P, Sam O, Jaiteh KO, Cubitt D, Milligan P, Whittle HC. Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. Aids 2003, 17:1841-1846. 10.1097/00002030-200311070-00015, 12891071.
2. van der Loeff MF, Awasana AA, Sarge-Njie R, van der Sande M, Jaye A, Sabally S, Corrah T, McConkey SJ, Whittle HC. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol 2006, 35:1322-1328. 10.1093/ije/dyl037, 16543363.
3. Los Alamos HIV Database. , http://www.hiv.lanl.gov/
4. Barouch DH, O'Brien KL, Simmons NL, King SL, Abbink P, Maxfield LF, Sun YH, La Porte A, Riggs AM, Lynch DM, et al. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med 16:319-323. 10.1038/nm.2089, 2834868, 20173752.
5. Santra S, Liao HX, Zhang R, Muldoon M, Watson S, Fischer W, Theiler J, Szinger J, Balachandran H, Buzby A, et al. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med 16:324-328. 10.1038/nm.2108, 2834806, 20173754.
6. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 2008, 82:3952-3970. 10.1128/JVI.02660-07, 2293010, 18256145.
7. Metabion. , http://www.metabion.com/
8. Macrogen. , http://www.macrogen.com/
9. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999, 41:95-98.
10. BioEdit. , http://www.mbio.ncsu.edu/bioedit/bioedit.html
11. Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 2000, 28:1102. 1104.
12. Sequence Manipulation Suite. , http://www.bioinformatics.org/sms2/orf_find.html
13. Meloni ST, Kim B, Sankale JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. J Virol 2004, 78:12438-12445. 10.1128/JVI.78.22.12438-12445.2004, 525043, 15507630.
14. Meloni ST, Sankale JL, Hamel DJ, Eisen G, Gueye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol 2004, 78:12455-12461. 10.1128/JVI.78.22.12455-12461.2004, 525044, 15507632.
15. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. Clustal W and Clustal × version 2.0. Bioinformatics 2007, 23:2947-2948. 10.1093/bioinformatics/btm404, 17846036.
16. EBI ClustalW2. , http://www.ebi.ac.uk/Tools/clustalw2/index.html
17. Phylogenetic analysis using parsimony and other methods. Version 4.0b10. , http://paup.csit.fsu.edu/paupfaq/faq.html
18. Felsenstein J. Maximum-likelihood estimation of evolutionary trees from continuous characters. Am J Hum Genet 1973, 25:471-492. 1762641, 4741844.
19. Yang Z. Estimating the pattern of nucleotide substitution. J Mol Evol 1994, 39:105-111.
20. Inkscape. , http://www.inkscape.org/
21. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17:754-755. 10.1093/bioinformatics/17.8.754, 11524383.
22. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999, 73:152-160. 103818, 9847317.
23. Gambian 2003 Census Data. , https://www.cia.gov/library/publications/the-world-factbook/fields/2075.html
24. Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, McCutchan FE. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology 1998, 247:22-31. 10.1006/viro.1998.9211, 9683568.
25. Abecasis AB, Lemey P, Vidal N, de Oliveira T, Peeters M, Camacho R, Shapiro B, Rambaut A, Vandamme AM. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. J Virol 2007, 81:8543-8551. 10.1128/JVI.00463-07, 1951349, 17553886.
26. Zhang M, Foley B, Schultz AK, Macke JP, Bulla I, Stanke M, Morgenstern B, Korber B, Leitner T. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7:25. 10.1186/1742-4690-7-25, 2855530, 20331894.
27. Bobkov A, Cheingsong-Popov R, Salminen M, McCutchan F, Louwagie J, Ariyoshi K, Whittle H, Weber J. Complex mosaic structure of the partial envelope sequence from a Gambian HIV type 1 isolate. AIDS Res Hum Retroviruses 1996, 12:169-171. 10.1089/aid.1996.12.169, 8834467.
28. Cham F, Heyndrickx L, Janssens W, Van der Auwera G, Vereecken K, De Houwer K, Coppens S, Whittle H, van der Groen G. Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res Hum Retroviruses 2000, 16:1915-1919. 10.1089/08892220050195874, 11118077.
29. Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004, 78:13232-13252. 10.1128/JVI.78.23.13232-13252.2004, 524984, 15542675.
30. Novitsky VA, Gaolekwe S, McLane MF, Ndung'u TP, Foley BT, Vannberg F, Marlink R, Essex M. HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. AIDS Res Hum Retroviruses 2000, 16:1015-1020. 10.1089/08892220050058434, 10890363.
31. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, Sema H, Tshimanga K, Bongo B, Delaporte E. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000, 74:10498-10507. 10.1128/JVI.74.22.10498-10507.2000, 110924, 11044094.
32. Ndiaye HD, Kane CT, Vidal N, Niama FR, Niang-Diallo PA, Dieye T, Gaye-Diallo A, Wade AS, Peeters M, Mboup S. Surprisingly High Prevalence of Subtype C and Specific HIV-1 Subtype/CRF Distribution in Men Having Sex With Men in Senegal. J Acquir Immune Defic Syndr 2009,
33. Hamel DJ, Sankale JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses 2007, 23:1189-1196. 10.1089/aid.2007.0037, 17961103.
34. Abecasis AB, Wang Y, Libin P, Imbrechts S, de Oliveira T, Camacho RJ, Vandamme AM. Comparative performance of the REGA subtyping tool version 2 versus version 1. Infect Genet Evol 10:380-385. 10.1016/j.meegid.2009.09.020, 19822224.
35. Njai HF, Gali Y, Vanham G, Clybergh C, Jennes W, Vidal N, Butel C, Mpoudi-Ngolle E, Peeters M, Arien KK. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006, 3:40. 10.1186/1742-4690-3-40, 1525194, 16817969.
36. Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, Johnston E, Katzenstein D, Siddiqui A, Herrera C, Fischetti L, et al. CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J Virol 2009, 83:5592-5605. 10.1128/JVI.02051-08, 2681953, 19297481.
37. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR, Fenyo EM, Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998, 241:181-188. 10.1006/viro.1997.8980, 9499793.
38. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999, 73:6271-6281. 112705, 10400718.
39. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002, 185:1244-1250. 10.1086/340130, 12001041.
40. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, et al. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008, 197:707-713. 10.1086/527416, 18266607.
41. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, Mandaliya K, Jaoko W, Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007, 195:1177-1180. 10.1086/512682, 17357054.
42. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999, 179:68-73. 10.1086/314557, 9841824.
43. Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, Liegeois F, Kane CT, Butel C, Mbuagbaw J, et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis 2002, 186:486-492. 10.1086/341833, 12195375.
44. Invernizzi CF, Coutsinos D, Oliveira M, Moisi D, Brenner BG, Wainberg MA. Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C. J Infect Dis 2009, 200:1202-1206. 10.1086/605894, 19764886.
45. Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA. Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). J Int AIDS Soc 2009, 12:11. 10.1186/1758-2652-12-11, 2713201, 19566959.